A Randomized, Phase Ib, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of SKB575 (HBM7575) in Participants With Asthma

NCT07732023 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma (Diagnosis)

Interventions

DRUG: SKB575
DRUG: Placebo

Sponsor

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.